Jnana Therapeutics picks up $50m Series B
Jnana Therapeutics, a biotechnology company, has secured $50 million in Series B financing.
Jnana Therapeutics, a biotechnology company, has secured $50 million in Series B financing.
Copyright PEI Media
Not for publication, email or dissemination